# Cannabis News Update: March 15, 2026 Highlights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-news-update-march-15-2026/ > **Published:** 2026-03-15T21:58:51-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:07:05-04:00 > **Clinical Summary:** Stay informed with the latest cannabis news update for March 15, 2026, covering research, legislation, and medical developments. --- AM News UpdateMarch 15, 2026. 5 cannabis news items, curated from live RSS feeds. Sorted by relevance score. [Does Cannabis Use by Older Adults Accelerate Mental Decline? – Labroots](https://www.labroots.com/trending/cannabis-sciences/30311/cannabis-adults-accelerate-mental-decline-2) # Summary This article examines research on whether cannabis use in older adults contributes to accelerated cognitive decline and discusses structural variations in synthetic cannabinoid compounds. [Read more →](https://www.labroots.com/trending/cannabis-sciences/30311/cannabis-adults-accelerate-mental-decline-2) [Study Found CBD and CBG May Counter Fatty Liver Disease​ | Cannabis Sciences](https://www.labroots.com/trending/cannabis-sciences/30310/study-found-cbd-cbg-counter-fatty-liver-disease-2) # Article Summary Research indicates cannabidiol (CBD) and cannabigerol (CBG) may have therapeutic potential in treating [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/), suggesting novel pharmacological approaches to hepatic lipid accumulation. [Read more →](https://www.labroots.com/trending/cannabis-sciences/30310/study-found-cbd-cbg-counter-fatty-liver-disease-2) [Connect to the Capitol: Budget battle, Clyburn to run again, tussle over THC | WTMA-AM](https://www.wtma.com/2026/03/15/connect-to-the-capitol-budget-battle-clyburn-to-run-again-tussle-over-thc/) # Summary This article covers South Carolina legislative developments including budget negotiations, Representative Clyburn’s reelection plans, and regulatory discussions regarding THC products. [Read more →](https://www.wtma.com/2026/03/15/connect-to-the-capitol-budget-battle-clyburn-to-run-again-tussle-over-thc/) [Breakthrough Laboratory Device Revolutionizes Cannabinoid Extraction and … – Tech Times](https://www.techtimes.com/articles/315178/20260314/breakthrough-laboratory-device-revolutionizes-cannabinoid-extraction-neurodegenerative-protein.htm) # Summary A new laboratory device using protein spectroscopy improves cannabinoid extraction and analysis, advancing analytical methods for potential neurodegenerative disease research. [Read more →](https://www.techtimes.com/articles/315178/20260314/breakthrough-laboratory-device-revolutionizes-cannabinoid-extraction-neurodegenerative-protein.htm) [Medical cannabis may soon be available in Alabama, almost five years after authorization](https://www.timesfreepress.com/news/2026/mar/15/medical-cannabis-may-soon-be-available-in-alabama/) Alabama is implementing [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) availability nearly five years after legislative authorization, with patient advocates like Amanda Taylor involved in the regulatory process. [Read more →](https://www.timesfreepress.com/news/2026/mar/15/medical-cannabis-may-soon-be-available-in-alabama/) Clinical Commentary Dr. Caplan’s Take # Clinical Reflection These items collectively reflect an evolving landscape where [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) is moving toward regulatory implementation while evidence generation continues in specific therapeutic areas, particularly around metabolic and neurodegenerative conditions. The focus on cannabinoid-specific effects like CBD and CBG for fatty liver disease, paired with legitimate concerns about cognitive impacts in older populations, underscores that responsible prescribing requires us to move beyond cannabis as a monolithic entity and instead individualize based on cannabinoid profile, patient demographics, and specific indications. The parallel advancement of extraction technology alongside state-level policy shifts suggests that within the next few years, clinicians will have both better access to standardized formulations and a growing body of pharmacological evidence to inform evidence-based practice, though we must remain vigilant about gaps in long-term safety data. Medical Cannabis[Cannabis Research](https://cedclinic.com/pediatric-cannabis-certification-care-children/)Health And WellnessLegislative PolicyScientific Innovation 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/ask-dr-caplan/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+News+Digest+%40drcaplan&url=)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+News+Digest+--+via+%40drcaplan.bsky.social+)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Connect to the Capitol: Budget Battle, Clyburn to Run Again, Tussle Over THC – WCIV](https://cedclinic.com/south-carolina-cannabis-regulation-2026-legislative-update/) Explore the latest legislative updates on cannabis regulation in South Carolina, including budget battles and THC policy discussions. [Read More](https://cedclinic.com/south-carolina-cannabis-regulation-2026-legislative-update/) [Daily Digest: Cannabinoids and Liver Disease Lead a Busy News Cycle — March 07, 2026](https://cedclinic.com/cognitive-safety-older-adults-cannabis-march-2026/) Discover recent research on cannabinoids like CBD and CBG and their potential in treating fatty liver disease. [Learn More](https://cedclinic.com/cognitive-safety-older-adults-cannabis-march-2026/) [The Best CBD for Immune Support and Daily Resilience in 2026 | stupidDOPE | Est. 2008](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) Find out about top [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) for immune support and daily wellness in 2026, backed by expert insights. [Explore Now](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).